Marilena Gubbiotti

ORCID: 0000-0002-3486-1226
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Urinary Bladder and Prostate Research
  • Pelvic floor disorders treatments
  • Urinary Tract Infections Management
  • Bladder and Urothelial Cancer Treatments
  • Urological Disorders and Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Sexual function and dysfunction studies
  • Child Nutrition and Feeding Issues
  • Botulinum Toxin and Related Neurological Disorders
  • Anorectal Disease Treatments and Outcomes
  • Systemic Sclerosis and Related Diseases
  • Ureteral procedures and complications
  • Pediatric Pain Management Techniques
  • Pelvic and Acetabular Injuries
  • Musculoskeletal pain and rehabilitation
  • Pain Mechanisms and Treatments
  • Hernia repair and management
  • Diet and metabolism studies
  • Restless Legs Syndrome Research
  • Long-Term Effects of COVID-19
  • Hormonal and reproductive studies
  • Parkinson's Disease Mechanisms and Treatments
  • Multiple Sclerosis Research Studies
  • Adolescent and Pediatric Healthcare
  • Gastrointestinal motility and disorders

Ospedale San Donato
2019-2024

Ospedale Santa Maria
2013-2024

Azienda Usl 8 Arezzo
2024

Media Working Group
2021

University of Perugia
2013-2019

Azienda Ospedaliera di Perugia
2017

Background: We investigated the effectiveness and safety of mirabegron oral treatment in a group patients with Parkinson’s disease (PD) overactive bladder (OAB), refractory to antimuscarinics. Materials methods: Thirty PD OAB were prospectively included study. At baseline, motor symptoms, severity cognitive status assessed Hoehn–Yahr Scale, Unified Rating Mini Mental State examination Montreal Cognitive Assessment. urinary satisfaction impact incontinence on quality life (QoL) 3-day voiding...

10.1177/1756286419843458 article EN cc-by-nc Therapeutic Advances in Neurological Disorders 2019-01-01

Background: the aim of this study was to perform an Italian telematics survey analysis on changes in couples’ sex lives during coronavirus disease 2019 (COVID-19) lockdown. Methods: a multicenter cross sectional conducted people sexually active and stable relationships for at least 6 months. To evaluate male female sexual dysfunctions, we used international index erectile function (IIEF-15) (FSFI), respectively; marital quality stability were evaluated by adjustment test (items 10–15);...

10.3390/jcm10071414 article EN Journal of Clinical Medicine 2021-04-01

Introduction To evaluate lower urinary tract symptoms (LUTS) and bowel disorders in a population of young subjects with autism spectrum disorder (ADS) by national survey to assess the relationship between occurrence, frequency, type LUTS severity behavioral neuropsychiatric characteristics. Materials methods A on ASD was sent mail social media through main Italian Associations February September 2022. The correlation also assessed. Results completed 502 mean age 16.6 years ± 10 years: male...

10.3389/fpsyt.2024.1140113 article EN cc-by Frontiers in Psychiatry 2024-03-11

PD-L1 represents a crucial immune checkpoint molecule in the tumor microenvironment, identified as key target for cancer immunotherapy. A correlation between and EMT-related genes expression various human cancers has been suggested.By ScreenCell filtration, digital droplet PCR confocal microscopy analysis, we aimed to investigate of EMT/invasive (TWIST1, ZEB1, VIMENTIN, TIMP2) circulating cells (CTCs) collected from blood non-muscle-invasive bladder (NMIBC) patients, assessing prognostic...

10.3390/cancers13235989 article EN Cancers 2021-11-28

Urinary symptoms associated with multiple sclerosis (MS) are common and negatively impact on quality of life, representing a considerable psychosocial economic burden, often requiring care hospitalization. Although the importance identifying adequately treating urinary in MS is now well recognized, there no information, to date, about real prevalence bladder patients clinically isolated syndromes (CISs) suggestive MS.The aim present study was investigate, cohort diagnosis CIS MS, tract...

10.1111/ene.12370 article EN European Journal of Neurology 2014-01-28

BACKGROUND: The management of recurrent female stress urinary incontinence (SUI) still needs worldwide standardization. Few data on the role urethral bulking agents (UBA) for treatment exist. aim this study is to assess efficacy and safety SUI.METHODS: A multicenter, prospective was conducted in four tertiary referral centers two countries. All consecutive women with urodynamically-proven SUI, a history previous failed anti-incontinence surgical procedure (mid-urethral sling or single...

10.23736/s2724-6051.21.04269-5 article EN Minerva Urology and Nephrology 2022-01-21

Abstract Introduction Although antibiotic prophylaxis (AB) demonstrated a statistically significant reduction in bacteriuria after invasive urodynamics (UDS), no decrease the incidence of urinary tract infections (UTI) has been confirmed. No absolute recommendations on use AB case relevant potential risk UTI have reported, though some categories patients at increased infective probability UDS recognized. The aim this study is to report experts' consensus best practice for before main...

10.1002/nau.25463 article EN Neurourology and Urodynamics 2024-04-08

Overactive bladder (OAB) can frequently exert a negative effect on female sexual function. Mirabegron, β3 receptor agonist, improves OAB symptoms, but there are very few information about its role dysfunction (FSD). Aim of the study was to assess impact Mirabegron FSD in women affected by OAB. Fifty sexually active suffering from idiopathic were included study. Patients assessed means urogynecologic physical examination and asked complete 3-day voiding diary, International Consultation...

10.1186/s12894-019-0438-8 article EN cc-by BMC Urology 2019-01-21
Coming Soon ...